In murine allergy models, IL-2 produced by adaptive immune cells has also been shown to augment IL-9 production35, so these results do not exclude other potentiating factors that might act in conjunction with IL-33 in CML mice. This evidence concerns the gene IL9 and chronic myelogenous leukemia, BCR-ABL1 positive.